Is CWSFF or JNJ a better dividend investment in 2026?

CWSFF currently yields 5934.72% with a 5% 5-year dividend growth rate. JNJ yields 2.14% with 5.8% growth. The better choice depends on your goal: CWSFF offers higher current income.

What is the dividend yield difference between CWSFF and JNJ?

CWSFF has a forward dividend yield of 5934.72% ($2.00/share annually). JNJ yields 2.14% ($5.20/share annually). The yield gap is 5932.58 percentage points.

Home › Compare › CWSFF vs JNJ

CWSFF vs JNJ: Dividend Comparison 2026

CWSFF yields 5934.72% · JNJ yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CWSFF wins by $330021154903866.88M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CWSFF

● Live price

5934.72%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$330021154903866.88M

Annual income

$319,433,066,642,118,540,000.00

Full CWSFF calculator →

JNJ

Johnson & Johnson

● Live price

2.14%

Share price

$242.49

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.5K

Annual income

$4,749.88

Full JNJ calculator →

Portfolio growth — CWSFF vs JNJ

📍 CWSFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CWSFF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CWSFF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CWSFF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CWSFF

Annual income on $10K today (after 15% tax)

$504,451.04/yr

After 10yr DRIP, annual income (after tax)

$271,518,106,645,800,750,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$182.28/yr

After 10yr DRIP, annual income (after tax)

$4,037.40/yr

At 15% tax rate, CWSFF beats the other by $271,518,106,645,800,750,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CWSFF + JNJ for your $10,000?

CWSFF: 50%JNJ: 50%

100% JNJ50/50100% CWSFF

Portfolio after 10yr

$165010577451933.44M

Annual income

$159,716,533,321,059,270,000.00/yr

Blended yield

96.79%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CWSFF

No analyst data

Altman Z

-946.4

Piotroski

2/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-5.7% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CWSFF buys

JNJ buys

No recent congressional trades found for CWSFF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCWSFFJNJ

Forward yield	5934.72% ✓	2.14%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$330021154903866.88M ✓	$30.5K
Annual income after 10y	$319,433,066,642,118,540,000.00 ✓	$4,749.88
Total dividends collected	$329308500369640.06M ✓	$15.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CWSFF vs JNJ ($10,000, DRIP)

Year	CWSFF Portfolio	CWSFF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$604,172	$593,471.81	$10,594	$274.49	+$593.6K → CWSFF
2	$34,156,645	$33,510,181.10	$11,294	$360.69	+$34.15M → CWSFF
3	$1,807,095,771	$1,770,548,161.01	$12,133	$476.91	+$1807.08M → CWSFF
4	$89,478,307,091	$87,544,714,616.13	$13,156	$635.42	+$89478.29M → CWSFF
5	$4,146,933,008,884	$4,051,191,220,296.45	$14,432	$854.61	+$4146932.99M → CWSFF
6	$179,909,379,896,891	$175,472,161,577,385.03	$16,056	$1,162.76	+$179909379.88M → CWSFF
7	$7,307,115,278,978,935	$7,114,612,242,489,262.00	$18,175	$1,604.53	+$7307115278.96M → CWSFF
8	$277,878,207,052,073,200	$270,059,593,703,565,760.00	$21,009	$2,252.68	+$277878207052.05M → CWSFF
9	$9,895,409,590,419,038,000	$9,598,079,908,873,320,000.00	$24,911	$3,229.73	+$9895409590419.01M → CWSFF
10	$330,021,154,903,866,900,000	$319,433,066,642,118,540,000.00	$30,458	$4,749.88	+$330021154903866.88M → CWSFF

CWSFF vs JNJ: Complete Analysis 2026

CWSFF — Stock

Cielo Waste Solutions Corp. operates as a waste-to-fuel environmental technology company in Canada. It converts and transforms waste feedstocks, including organic material and wood derivative waste into fuel, such as diesel, naphtha, and kerosene. The company was formerly known as Cielo Gold Corp. and changed its name to Cielo Waste Solutions Corp. in August 2013. Cielo Waste Solutions Corp. was incorporated in 2011 and is headquartered in Calgary, Canada.

Full CWSFF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this CWSFF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CWSFF vs SCHD CWSFF vs JEPI CWSFF vs O CWSFF vs KO CWSFF vs MAIN CWSFF vs ABBV CWSFF vs MRK CWSFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.